A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes
Clinical trial NCT00236626 · COMPLETED
Trial details
- NCT number
- NCT00236626
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.